Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Feb;47(2):104-113.
doi: 10.1111/1346-8138.15184. Epub 2019 Dec 13.

Dendritic cells: The driver of psoriasis

Ao Wang  1   2 , YanPing Bai  1   2
Affiliations
Review

Dendritic cells: The driver of psoriasis

Ao Wang et al. J Dermatol. 2020 Feb.

Abstract

Psoriasis is a chronic skin inflammatory disorder, the immune mechanism of which has been profoundly elucidated in the past few years. The dominance of the interleukin (IL)-23/IL-17 axis is a significant breakthrough in the understanding of the pathogenesis of psoriasis, and treatment targeting IL-23 and IL-17 has successfully benefited patients with the disease. The skin contains a complex network of dendritic cells (DC) mainly composed of epidermal Langerhans cells, bone marrow-derived dermal conventional DC, plasmacytoid DC and inflammatory DC. As the prominent cellular source of α-interferon, tumor necrosis factor-α, IL-12 and IL-23, DC play a pivotal role in psoriasis. Thus, targeting pathogenic DC subsets is a valid strategy for alleviating and preventing psoriasis and other DC-derived diseases. In this review, we survey the known role of DC in this disease.

Keywords: Langerhans cells; dendritic cells; interleukin-23; psoriasis; α-interferon.

PubMed Disclaimer

References

    1. Lowes MA, Suarez-Farinas M, Krueger JG. Immunology of psoriasis. Annu Rev Immunol 2014; 32: 227-255.
    1. Boehncke WH, Schon MP. Psoriasis. Lancet 2015; 386(9997): 983-994.
    1. Bochenska K, Smolinska E, Moskot M, Jakobkiewicz-Banecka J. Gabig-Ciminska M. Models in the Research Process of Psoriasis. Int J Mol Sci 2017; 18(12): 2514.
    1. Kamiya K, Kishimoto M, Sugai J, Komine M, Ohtsuki M. Risk factors for the development of psoriasis. Int J Mol Sci 2019; 20(18): 4347.
    1. Chiricozzi A, Romanelli P, Volpe E, Borsellino G, Romanelli M. Scanning the Immunopathogenesis of Psoriasis. Int J Mol Sci 2018; 19(1): 179.

MeSH terms